Search

Your search keyword '"Al-Abdouh, Ahmad"' showing total 459 results
Start Over Author "Al-Abdouh, Ahmad"
459 results on '"Al-Abdouh, Ahmad"'

11. Trends in surgical and transcatheter interventions for tricuspid regurgitation: A national inpatient sample analysis from 2011 to 2020

Author

Villablanca, Pedro, Jabri, Ahmad, Alhuneafat, Laith, Maligireddy, Anand, Rasheed, Waqas, Kapcin, Kyle, Manalo, Katie, Latib, Azeem, Giustino, Gennaro, Fadel, Raef, Al Abdouh, Ahmad, Mhanna, Mohammed, Amoroso, Nicholas, Wang, Dee Dee, O'Neill, Brian, Bagur, Rodrigo, Madanat, Luai, Renard, Brian, Aggarwal, Vikas, Alqarqaz, Mohammad, So, Kent, Genereux, Philippe, Hanson, Ivan D., Abbas, Amr E., and O'Neill, William W.

Published
2024
Full Text
View/download PDF

12. Outcomes following TAVR in patients with cardiogenic shock: A systematic review and meta-analysis

Author

Jabri, Ahmad, Ayyad, Mohammed, Albandak, Maram, Al-Abdouh, Ahmad, Madanat, Luai, Khalefa, Basma Badrawy, Alhuneafat, Laith, Ayyad, Asem, Lemor, Alejandro, Mhanna, Mohammed, Al Jebaje, Zaid, Fadel, Raef, Gonzalez, Pedro Engel, O'Neill, Brian, Bagur, Rodrigo, Hanson, Ivan D., Abbas, Amr E., Frisoli, Tiberio, Lee, James, Wang, Dee Dee, Aggarwal, Vikas, Alaswad, Khaldoon, O'Neill, William W., Aronow, Herbert D., AlQarqaz, Mohammad, and Villablanca, Pedro

Published
2024
Full Text
View/download PDF

15. Progression of valvular calcification and risk of incident stroke: The Multi-Ethnic Study of Atherosclerosis (MESA)

Author

Fashanu, Oluwaseun E, Bizanti, Anas, Al-Abdouh, Ahmad, Zhao, Di, Budoff, Matthew J, Thomas, Isac C, Longstreth, WT, and Michos, Erin D

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Clinical Sciences, Cardiovascular, Heart Disease, Neurosciences, Heart Disease - Coronary Heart Disease, Clinical Research, Minority Health, Prevention, Stroke, Brain Disorders, Aging, Atherosclerosis, Cerebrovascular, Aged, Aortic Valve Stenosis, Calcinosis, Ethnicity, Female, Heart Valve Diseases, Humans, Male, Middle Aged, Risk Factors, Valvular calcification, Epidemiology, Aortic valvular calcification, Mitral annular calcification, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology, Clinical sciences
Abstract

Background and aimsPrevalent valvular calcification (VC) is associated with stroke but little is known about associations of VC progression with stroke.MethodsProgression (interval increase >0 Agatston units/year) of aortic valvular calcification (AVC) and mitral annular calcification (MAC) was assessed by two cardiac CTs over a median of 2.4 years. We determined the risk of adjudicated total and ischemic stroke using Cox regression adjusted for cardiovascular disease (CVD) risk factors.ResultsWe studied 5,539 MESA participants free of baseline CVD and atrial fibrillation. Baseline mean ± SD age was 62 ± 10 years; 53% were women; 83% had no progression of VC; 15%, progression at one site (AVC or MAC), and 3%, progression at both sites. Over a median of 12 years, 211 total and 167 ischemic strokes occurred. The number of sites with VC progression (range 0-2) was not associated with total and ischemic stroke (all p > 0.05). We found MAC progression to be associated with increased risk of total stroke [adjusted hazard ratio (95% CI) 1.59 (1.11, 2.28)] and ischemic stroke [1.64 (1.10, 2.45)]. Results remained significant after further adjustment for baseline coronary artery calcification. After excluding participants with interim atrial fibrillation and coronary heart disease, findings were no longer statistically significant in fully-adjusted models. There was no interaction by age, sex, or race/ethnicity. There was no association with AVC progression and stroke.ConclusionsProgression of MAC but not AVC over 2.4 years is associated with increased risk of total and ischemic stroke.

Published
2020

42. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Author

Sabina, Michael, Shah, Shrinand, Grimm, Mason, Daher, Jean Carlo, Campillo, Paola, Boozo, Mohammed Baraa, Al-Abdouh, Ahmad, Abusnina, Waiel, D' Ascenzo, Fabrizio, and Bizanti, Anas

Subjects
MYOCARDIAL infarction, PERCUTANEOUS coronary intervention, VENTRICULAR ejection fraction, STROKE, MORTALITY
Abstract

Background: The benefit of beta-blockers (BBs) for myocardial infarction (MI) patients with a preserved left ventricular ejection fraction (LVEF) is uncertain. While beneficial for a reduced LVEF, their efficacy with a preserved LVEF, especially with modern revascularization, is unclear. Methods: A PRISMA-guided systematic review and meta-analysis utilized PubMed and EMBASE. Three randomized controlled trials comparing outcomes in MI patients with a preserved LVEF treated with BBs versus no treatment were included. The primary outcome was composite all-cause mortality and MI; secondary outcomes were all-cause mortality, cardiovascular mortality, MI, and stroke. Results: Three studies, including a total of 9512 participants, were analyzed. Beta-blockers did not demonstrate a statistically significant benefit in reducing the composite endpoint of all-cause mortality and myocardial infarction (RR 0.97, 95% CI: 0.84–1.12, p = 0.671, I2 = 0%). Similarly, no significant effect was observed for secondary outcomes: all-cause mortality (RR 0.96, 95% CI: 0.79–1.17, p = 0.708), cardiovascular mortality (RR 1.22, 95% CI: 0.87–1.72, p = 0.247), myocardial infarction (RR 0.97, 95% CI: 0.78–1.19, p = 0.759), and stroke (RR 0.96, 95% CI: 0.66–1.38, p = 0.819). Conclusions: In patients with myocardial infarction and a preserved LVEF, beta-blockers did not significantly reduce mortality, recurrent myocardial infarction, or stroke, suggesting a limited benefit in this population under contemporary management protocols. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results